jasmine m miller kleinhenz - Epidemiology

Author Information

Jasmine M. Miller-Kleinhenz is a prominent researcher in the field of epidemiology, currently affiliated with the Department of Epidemiology at Emory University Rollins School of Public Health in Atlanta, Georgia. Her work primarily focuses on understanding and addressing health disparities, particularly in relation to cancer outcomes.

Research Contributions

Jasmine M. Miller-Kleinhenz has made significant contributions to the field of epidemiology, with a keen focus on the impact of structural racism, neighborhood characteristics, and healthcare facility attributes on cancer outcomes. Her research explores how social determinants of health, such as redlining and lending bias, affect cancer mortality and tumor biology, particularly in breast cancer. Additionally, she has delved into the disparities in gastrointestinal cancer mortality among diverse populations. Her work aims to change the academic conversations around race and improve diagnostic and treatment protocols to mitigate racial disparities in cancer care.

Aliases

Jasmine M. Miller-Kleinhenz is also known by several aliases, including Jasmine M Miller-kleinhenz, Jasmine Miller-kleinhenz, and Jasmine Miller-Kleinhenz.

Publication and Citation Metrics

Metric	Value
Citation Count	295
H-Index	8
Paper Count	25

Publications:

Abstract PR-03: Neighborhood-level redlining-associated methylation in breast tumors: The impact of structural racism on the tumor epigenome

DOI: 10.1158/1538-7755.disp21-pr-03

Year: 2022

Understanding gastrointestinal cancer mortality disparities in a racially and geographically diverse population.

DOI: 10.1016/j.canep.2022.102110

Year: 2022

Neighborhood characteristics and breast tumor methylation: using epigenomics to explore cancer outcome disparities

DOI: 10.1007/s10549-021-06430-1

Year: 2022

Time to Surgical Treatment and Facility Characteristics as Potential Drivers of Racial Disparities in Breast Cancer Mortality

DOI: 10.1245/s10434-022-11720-z

Year: 2022

ASO Visual Abstract: Time to Surgical Treatment and Facility Characteristics as Potential Drivers of Racial Disparities in Breast Cancer Mortality: Delay, Facilities, and Breast Cancer Mortality

DOI: 10.1245/s10434-022-11794-9

Year: 2022

Let’s talk about race: changing the conversations around race in academia

DOI: 10.1038/s42003-021-02409-2

Year: 2021

Racial Disparities in Diagnostic Delay Among Women With Breast Cancer.

DOI: 10.1016/j.jacr.2021.06.019

Year: 2021

Receipt of Guideline-Concordant Care Does Not Explain Breast Cancer Mortality Disparities by Race in Metropolitan Atlanta.

DOI: 10.6004/jnccn.2020.7694

Year: 2021

Crown-Like Structures in Breast Adipose Tissue: Early Evidence and Current Issues in Breast Cancer

DOI: 10.3390/cancers13092222

Year: 2021

Neighborhood-Level Redlining and Lending Bias Are Associated with Breast Cancer Mortality in a Large and Diverse Metropolitan Area

DOI: 10.1158/1055-9965.EPI-20-1038

Year: 2020

What is the Purpose of MMWR?

What Were the Key Findings?

How Does Knowledge of Pathogenesis Aid in Disease Prevention?

What is Central Tendency?

What are the Challenges in Maintaining Biosafety?

What Challenges Exist in Implementing Hygiene Practices?

What are the Challenges in ME Research?

Why are Health Disparities Important in Epidemiology?

What is the Source?

Why is the Rate of Transmission Important?

Partnered Content Networks

Relevant Topics